Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

3 No-Brainer Artificial Intelligence (AI) Stocks to Buy Right Now
3 No-Brainer Artificial Intelligence (AI) Stocks to Buy Right Now

Wall Street is in the throes of earnings season, with the world's top businesses checking in at the halfway point of 2025. It's a crucial time for investors. There have been virtually no signs of

Why Is Everyone Talking About Novo Nordisk Stock?
Why Is Everyone Talking About Novo Nordisk Stock?

The pharma giant is facing stiff competition that is hurting sales of its weight loss and diabetes treatments.

*Stock prices used were the afternoon prices of Aug. 3, 2025. The video was published

Geron (GERN) Q2 Revenue Jumps 5,477%
Geron (GERN) Q2 Revenue Jumps 5,477%

Geron (NASDAQ:GERN), a biotechnology company focused on therapies for blood disorders, released its second quarter 2025 results on August 6, 2025. The headline news was a sharp acceleration in

Werner (WERN) Q2 2025 Earnings Call Transcript
Werner (WERN) Q2 2025 Earnings Call Transcript

Image source: The Motley Fool.

Tuesday, July 29, 2025, at 5 p.m. ET

Need a quote from one of our analysts? Email [email protected]

Continue reading

Source Fool.com

EQS-News: freenet exceeds expectations for free cash flow – customer base and service revenues continue to grow, guidance for adjusted EBITDA and free cash flow confirmed
EQS-News: freenet exceeds expectations for free cash flow – customer base and service revenues continue to grow, guidance for adjusted EBITDA and free cash flow confirmed
EQS-News: freenet exceeds expectations for free cash flow – customer base and service revenues continue to grow, guidance for adjusted EBITDA and free cash flow confirmed
Should Investors Buy Palantir Stock?
Should Investors Buy Palantir Stock?

Palantir (NASDAQ: PLTR) keeps surprising investors with its phenomenal growth across all critical performance metrics.

*Stock prices used were the afternoon prices of Aug. 3, 2025. The video was

Jazz (JAZZ) Q2 Revenue Rises 2%
Jazz (JAZZ) Q2 Revenue Rises 2%

Jazz Pharmaceuticals (NASDAQ:JAZZ) is a global biopharmaceutical company focused on innovative therapies for neuroscience and rare oncology diseases. On August 5, 2025, it reported second quarter

41 States That Don't Tax Social Security Benefits
41 States That Don't Tax Social Security Benefits

Taxes are virtually impossible to avoid in modern American life. There are taxes on income, purchases, property, and even Social Security benefits. Paying taxes doesn't necessarily leave people

These Were the 2 Best-Performing Stocks in the Nasdaq-100 in July 2025
These Were the 2 Best-Performing Stocks in the Nasdaq-100 in July 2025

Last month was another solid one for the Nasdaq-100 index. All told, it advanced by 3.3%, bolstering the index's excellent year-to-date performance of 8.3%. However, some stocks significantly

Ultra Clean (UCTT) Q2 2025 Earnings Call Transcript
Ultra Clean (UCTT) Q2 2025 Earnings Call Transcript

Image source: The Motley Fool.

Monday, July 28, 2025, 4:45 p.m. ET

Need a quote from one of our analysts? Email [email protected]

Continue reading

Source Fool.com

Tariffs and Trade Wars Can't Slow Big Tech's Momentum
Tariffs and Trade Wars Can't Slow Big Tech's Momentum

In this podcast, Motley Fool contributors Lou Whiteman, Rachel Warren, and Jon Quast discuss:

To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. When you're

ODP (ODP) Fiscal Q2 EPS Jumps 42%
ODP (ODP) Fiscal Q2 EPS Jumps 42%

ODP (NASDAQ:ODP), the office supply and business solutions company behind Office Depot and OfficeMax, reported its fiscal Q2 2025 earnings on August 6, 2025. The headline news is that adjusted

Spyre (SYRE) Q2 R&D Up 23% Loss Narrows
Spyre (SYRE) Q2 R&D Up 23% Loss Narrows

Spyre Therapeutics (NASDAQ:SYRE), a clinical-stage biotechnology company focused on antibody therapies for inflammatory diseases, released its second quarter results on August 5, 2025. Notably, Q2

This Company Looks Like a Dividend Champion in the Making and It Could Announce Another Dividend Hike Next Month
This Company Looks Like a Dividend Champion in the Making and It Could Announce Another Dividend Hike Next Month

Finding a company that can consistently increase its dividend year after year is the ultimate investment for many. But established dividend payers can often provide shareholders with nominal raises

Massive News for UnitedHealth Stock Investors
Massive News for UnitedHealth Stock Investors

The healthcare giant is experiencing one of its most challenging years in a very long time.

*Stock prices used were the afternoon prices of Aug. 2, 2025. The video was published on Aug. 4, 2025.

Bankwell (BWFG) Q2 2025 Earnings Call Transcript
Bankwell (BWFG) Q2 2025 Earnings Call Transcript

Image source: The Motley Fool.

Monday, July 28, 2025, at 11 a.m. ET

Need a quote from one of our analysts? Email [email protected]

Continue reading

Source Fool.com

National Vision (EYE) Sales Jump 8%
National Vision (EYE) Sales Jump 8%

National Vision (NASDAQ:EYE), a major value-focused optical retailer, released its results for the fiscal second quarter ended June 29, 2025, on August 6, 2025. It delivered GAAP revenue and

The Fed's Inflation Conundrum & an AI Billionaire Battle Royale
The Fed's Inflation Conundrum & an AI Billionaire Battle Royale

In this podcast, Motley Fool analyst Jason Moser and contributors Travis Hoium and Lou Whiteman discuss:

To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center

4 Important Earnings Takeaways From Opendoor Technologies
4 Important Earnings Takeaways From Opendoor Technologies

Real estate technology company Opendoor Technologies (NASDAQ: OPEN) has been one of the best-performing stocks in the market recently. The clear leader in the iBuying industry, Opendoor recently

Evolus (EOLS) Q2 Revenue Rises 4%
Evolus (EOLS) Q2 Revenue Rises 4%

Evolus (NASDAQ:EOLS), a performance beauty company specializing in aesthetic neurotoxins and hyaluronic acid (HA) dermal fillers, reported Q2 2025 results on August 5, 2025. The headline news is a

Intel Can't Stop Cutting
Intel Can't Stop Cutting

In this podcast, Motley Fool analyst Tim Beyers and contributor Jose Najarro discuss:

To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. When you're ready

United Health Services (UHS) Q2 2025 Earnings Call Transcript
United Health Services (UHS) Q2 2025 Earnings Call Transcript

Image source: The Motley Fool.

Tuesday, July 29, 2025, at 9 a.m. ET

Need a quote from one of our analysts? Email [email protected]

Continue reading

Source Fool.com

Trimble (TRMB) Fiscal Q2 EPS Jumps 14%
Trimble (TRMB) Fiscal Q2 EPS Jumps 14%

Trimble (NASDAQ:TRMB), a leader in connected workflow technology for industries like construction, agriculture, and transportation, reported its earnings for the second quarter of fiscal 2025 on

Omega Healthcare (OHI) Q2 2025 Earnings Transcript
Omega Healthcare (OHI) Q2 2025 Earnings Transcript

Image source: The Motley Fool.

Friday, Aug. 1, 2025, 10 a.m. ET

For analyst commentary, contact [email protected]

Continue reading

Source Fool.com

A Rough Day for "Dividend Knights"
A Rough Day for "Dividend Knights"

In this podcast, Motley Fool analysts Emily Flippen, Matt Argersinger, and Anthony Schiavone dig into:

To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center